Theragnostics Is A Biopharmaceutical Company Based In Londonukfounded In 2015The Company Specializes In Developing Radio Labeled Parp Inhibitors Aimed At Improving Diagnosis And Treatment In Oncologytheir Focus Is On Enhancing Targeted Molecular Radiotherapy And Molecular Imaging Diagnostics To Transform Patient Care In Cancer Treatment In June 2023Theragnostics Was Acquired By Ariceum Therapeuticsa Berlin Based Radiopharmaceutical Companythis Acquisition Included An Upfront Payment And Potential Milestone Paymentsallowing Theragnosticsassets And Projects To Be Integrated Into Ariceum S Portfoliothe Company Has Also Filed Several Patents Related To Medical Imaging And Radiation Therapycontributing To Advancements In The Field
No conferences found for this company.
| Company Name | Theragnostics Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
